Arbutus Biopharma Corp (NASDAQ:ABUS)

6.80
Delayed Data
As of Jun 22
 +0.425 / +6.67%
Today’s Change
3.20
Today|||52-Week Range
8.25
+34.65%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close6.38
Today’s open6.40
Day’s range6.30 - 6.90
Volume4,083,995
Average volume (3 months)222,530
Market cap$366.9M
Data as of 4:00pm ET, 06/22/2018

Growth & Valuation

Earnings growth (last year)+78.45%
Earnings growth (this year)-0.48%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+617.64%
P/E ratioNM
Price/Sales25.83
Price/Book2.76

Competitors

 Today’s
change
Today’s
% change
ARDXArdelyx Inc+0.05+1.22%
DRRXDURECT Corp-0.03-1.52%
CPRXCatalyst Pharmaceuti...+0.21+6.60%
PETXAratana Therapeutics...+0.08+1.77%
Data as of 4:00pm ET, 06/22/2018

Financials

Next reporting dateAugust 14, 2018
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$10.7M
Annual profit (last year)-$84.4M
Net profit margin-788.91%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial Officer
David C. Hastings
Corporate headquarters
Burnaby, British Columbia

Forecasts